Can diaphragm flattening be caused by a large pleural (infrapulmonary) effusion versus pleural thickening, and what is the appropriate treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diaphragm Flattening: Causes and Treatment

Large pleural effusions cause diaphragm flattening by displacing the diaphragm downward and altering its shape, while pleural thickening can restrict diaphragmatic motion but typically does not cause the classic "flattening" appearance—the primary mechanism and treatment focus should be on the effusion itself.

Understanding the Mechanism

Pleural Effusion as the Primary Cause

Large pleural effusions cause diaphragm flattening through several interconnected mechanisms:

  • Direct displacement: Fluid accumulation increases pleural pressure, pushing the diaphragm downward and outward, distorting its normal dome shape 1, 2
  • Chest wall expansion: Rather than simply compressing the lung, effusions primarily expand the thoracic cage volume, including abnormal diaphragmatic positioning 3, 4
  • Impaired contractility: The altered length-tension relationship of the diaphragmatic muscle reduces its effectiveness and efficiency 2, 4

The severity of diaphragm dysfunction correlates with effusion size: small effusions (excursion 4.3 ± 2.1 cm), moderate effusions (3.2 ± 1.7 cm), and large effusions (1.1 ± 1.8 cm during deep inspiration) 1.

Pleural Thickening: A Different Entity

Pleural thickening represents chronic fibrotic changes rather than acute displacement. While it can restrict diaphragmatic motion, it does not typically produce the radiographic "flattening" seen with large effusions 5. Pleural thickening is more commonly associated with:

  • Chronic inflammatory processes
  • Post-pleurodesis changes
  • Complicated silicosis or asbestos exposure 5

Critical distinction: If you see diaphragm flattening on imaging, suspect a large effusion first—not isolated pleural thickening.

Treatment Algorithm

Step 1: Assess Symptoms and Effusion Size

For asymptomatic patients: Do not perform therapeutic interventions regardless of effusion size 6.

For symptomatic patients with dyspnea: Proceed based on effusion characteristics.

Step 2: Initial Diagnostic and Therapeutic Thoracentesis

Perform large-volume thoracentesis (ultrasound-guided) to accomplish three goals 6, 7:

  1. Assess whether symptoms improve with drainage
  2. Determine if the lung expands fully (expandable vs. nonexpandable lung)
  3. Obtain fluid for diagnostic analysis

Key technical points 7:

  • Remove 1-1.5 L initially if no pleural pressure monitoring available
  • Can safely remove larger volumes if contralateral mediastinal shift present and patient tolerates without chest tightness, cough, or dyspnea
  • Stop if pleural pressure drops below -20 cm H₂O (risk of re-expansion pulmonary edema)

Step 3: Definitive Management Based on Lung Expansion

If Lung Expands Completely (Expandable Lung)

Choose either option based on patient preference and clinical context 6:

Option A: Chemical Pleurodesis

  • Use talc poudrage (via thoracoscopy) OR talc slurry (via chest tube)
  • Requires hospitalization initially
  • Best for patients who want definitive single intervention

Option B: Indwelling Pleural Catheter (IPC)

  • Outpatient placement possible
  • Reduces hospital time
  • Higher risk of cellulitis but allows home management
  • Consider daily drainage if IPC removal is a priority (increases pleurodesis rates) 8

If Lung Does Not Expand (Nonexpandable Lung)

Use IPC instead of attempting pleurodesis 6.

Nonexpandable lung is suggested by:

  • Absence of contralateral mediastinal shift despite large effusion 7
  • Initial pleural fluid pressure <10 cm H₂O at thoracentesis 7
  • Pleural pressure >19 cm H₂O after removing 500 mL fluid 7
  • Trapped lung from extensive pleural tumor infiltration or endobronchial obstruction 7

Step 4: Special Considerations

For septated/loculated effusions: Consider intrapleural fibrinolytics to improve drainage before definitive therapy, which may shorten hospital stay and decrease pleurodesis failure 8.

If dyspnea persists after drainage: Investigate alternative causes including lymphangitic carcinomatosis, atelectasis, pulmonary embolism, or tumor embolism 7.

Expected Outcomes After Drainage

Drainage improves diaphragmatic function through 2, 4:

  • Restoration of diaphragmatic displacement and thickening
  • Decreased respiratory drive and work of breathing
  • Improved neuromechanical coupling of the diaphragm
  • Enhanced respiratory system compliance

Important caveat: Improvements in lung volumes are often modest and correlate poorly with the volume drained—symptom relief primarily results from restored diaphragmatic mechanics, not simply lung re-expansion 3, 4.

Common Pitfalls to Avoid

  1. Don't drain asymptomatic effusions just because they're present 6
  2. Don't attempt pleurodesis with nonexpandable lung—it will fail and delay appropriate IPC placement 6
  3. Don't remove excessive fluid rapidly without monitoring—risk of re-expansion pulmonary edema 7
  4. Don't assume pleural thickening alone causes acute diaphragm flattening—look for concurrent effusion 5

References

Research

Drainage of pleural effusion improves diaphragmatic function in mechanically ventilated patients.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2017

Research

Physiology of breathlessness associated with pleural effusions.

Current opinion in pulmonary medicine, 2015

Research

Pathophysiology of dyspnoea in pleural effusion.

Breathe (Sheffield, England), 2025

Guideline

management of malignant pleural effusions. an official ats/sts/str clinical practice guideline.

American Journal of Respiratory and Critical Care Medicine, 2018

Guideline

management of malignant pleural effusions.

American Journal of Respiratory and Critical Care Medicine, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.